Adial Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €60.16M +104.3% €2.83M -140.5% 4.7% +0.28 pp N/A N/A
    (estimated) €29.44M +∞% -€6.99M -58.6% -23.8% -0.24 pp N/A N/A
    (estimated) €0.00 +NaN% -€16.90M +86.9% N/A N/A N/A
    (estimated) €0.00 +NaN% -€9.04M +24.4% N/A N/A N/A
    (estimated) €0.00 +NaN% -€7.27M -35.7% N/A N/A N/A
    €0.00 +NaN% -€11.30M +88.5% N/A -€5.93M -49.2% N/A
    €0.00 +NaN% -€5.99M -45.0% N/A -€11.65M +21.7% N/A
    €0.00 +NaN% -€10.90M -34.5% N/A -€9.58M -5.9% N/A
    €0.00 +NaN% -€16.63M +78.8% N/A -€10.17M +55.7% N/A
    €0.00 +NaN% -€9.30M +26.4% N/A -€6.53M +20.4% N/A
    €0.00 +NaN% -€7.36M -26.1% N/A -€5.43M +153.7% N/A
    €0.00 +NaN% -€9.96M +920.8% N/A -€2.14M +404.9% N/A
    €0.00 +NaN% -€975.48K +171.2% N/A -€423.65K +80.4% N/A
    €0.00 +NaN% -€359.73K -48.6% N/A -€234.90K -41.0% N/A
    €0.00 -€700.28K N/A -€398.27K N/A

    Notifications